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INTRODUCTION
Magnetic resonance in clinical imaging and diagnosis provides
diagnostic capabilities never previously enjoyed by the medi-
cal community. However, the quality of information obtained
depends on the choice of instrument parameters. Before an MR
examination can be designed, the operator must be aware of
the consequences of the scanning parameter choices made, as
they will determine the success or failure of the study.1
The contrast agent gadolinium–diethylene triamine penta-
acetic acid (Gd-DTPA) reduces T1 and T2 relaxation times and
creates very complex changes in the MRI signal.2 Although Gd-
DTPA has been used as a contrast agent in MRI, it is known 
that the contrast enhancement effect disappears if the
concentration of Gd-DTPA increases beyond some levels.3–6
Therefore, the determination of Gd-DTPA concentrations 
in vitro to provide optimal MRI signal intensity (SI) is vital to
produce an image of the highest quality. On the other hand, it
must be noted that the optimal pulse sequence will vary with
field strength because of the frequency dependence of tissue 
T1 relaxation times. A number of models, which describe 
the influence of the magnetic field strength on both T1 and T2
relaxation times, predict a significant increase in T1 and a
decrease in T2 when using higher magnetic field strengths.4,7
This decrease may result from the combination of susceptibility
effects at elevated magnetic fields and diffusing of spins,
resulting in a decreased value of T2.
To investigate further whether SI with a contrast agent in
blood is similar to SI with the contrast agents in soft tissue,
melanoma cells were incubated in different concentrations of
Gd-DTPA before MRI. These results were validated by
experiments using magnetic field strengths of 1.9 Tesla for
measurements of longitudinal relaxation rates in melanotic
melanoma.8
The major goal of this work is to investigate the various MR
parameters and their interdependence and to determine the
optimal concentration of Gd-DTPA to enhance signal intensity
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for in vitro studies at a high magnetic field strength. To this end,
the SI of MRI in aqueous solutions of Gd-DTPA, aqueous
solutions of sodium chloride in the presence of Gd-DTPA, blood
and melanoma cells were measured with high magnetic field
apparatus at 7.0 Tesla.
MATERIALS AND METHODS
Magnetic resonance images were obtained on a 300 MHz, 
7.0 Tesla, Varian UNITY Plus (Varian Associated, Inc., Los
Angeles, CA, USA) with a vertical magnet of bore size 89 mm
(Oxford Instruments, Oxford, UK) using the saddle coil res-
onator. Five different types of samples were investigated in this
work.
First, Gd-DTPA (Sigma Chemical Co., Aldrich, CA, USA)
was dissolved in distilled water at different concentrations of
0.4–6.0 mmol/L. The volume of each Gd-DTPA was 1 mL, and
each solution was put into a 5 mm nuclear magnetic resonance
(NMR) test tube.
Second, a phantom containing seven tubes of aqueous
solution of sodium chloride (5 mol/L) with different concentra-
tions of Gd-DTPA was used. The concentrations of Gd-DTPA
are the same as given earlier.
Third, different concentrations of sodium chloride solution
(0, 0.3, 0.6, 1, 1.2, 2.5, 3.3 and 5 mol/L) were prepared in eight
NMR test tubes filled with the same concentration of Gd-DTPA
(4 mmol/L).These were grouped together for MRI.
Fifteen NMR test tubes with concentrations of 0–6 mmol/L
Gd-DTPA in blood were then prepared. The SI measurements
of these samples were carried out using the same experimental
conditions as for the previous experiments (e.g. the same coil
and pulse sequence).
Different solutions of Gd-DTPA (0–6 mmol/L) were added 
to melanoma cells (MM-138; Cancer Care Centre, St George
Hospital, Sydney, NSW, Australia) and incubated. After 45 min,
samples were placed into the centrifuge for 15 min at a speed of
1500 r.p.m. The cells were placed in fetal bovine serum and
refrigerated for 12 h. The solution was separated from the cells
and the cells inserted into 30-mm NMR test tubes for MRI.
In vitro T1 and T2 relaxation times measurements were made
using an imaging probe in aqueous solutions (0–20 mmol/L of
Gd-DTPA), blood samples and melanoma cells (0–10 mmol/L
of Gd-DTPA). The T1 and T2 measurements were performed
using inversion recovery (IR) and Carr-Purcell-Meiboom-Gill
(CPMG) pulse sequence, respectively. Relaxivities were then
determined from the slope of the graph of relaxation rates as a
function of Gd-DTPA concentrations.
All of these experiments were carried out using the same
parameters. A conventional IR sequence was used and typical
values were as follows: relaxation delay time (TR) = 1000 ms,
echo time (TE) = 30 ms, inverse delay time (TI) = 200 ms, slice
thickness = 3 mm, field of view 25 mm × 25 mm, number of
excitations (NEX) = 8, and matrix size = 512 × 28 or 512 × 256.
A selective (sinc) RF pulse sequence with a flip angle of 180°
was used for excitation. The voxel resolution was 2.1 mm ×
2.1 mm × 2 mm.
In vitro SI measurements were performed by selecting
voxels in the transfer image display.The brightness of any of the
picture elements (pixels) is related directly to the intensity of the
MR signal broadcasted by the corresponding voxel.5 Five signal
intensity measurements were chosen randomly for each voxel
and an average of those was calculated as the SI. Signal
intensities were normalized for a standard sample of 3 mmol/L
of Gd-DTPA solution.
The MRI SI measurements for Gd-DTPA solutions were
performed in two steps. First, the signal intensity was measured
for each sample. In the second step, all of the samples,
including seven NMR test tubes, were inserted in a 35 mm NMR
test tube. The relationship between signal intensity and
concentration of Gd-DTPA was also studied in two separate
experiments. First, the contrast image of each sample was
measured individually and second, all concentration samples
were grouped together in a simple image.
RESULTS
Signal intensity and concentration of 
Gd-DTPA solution
In the case of sample experiments measured individually, 
the concentration of aqueous solution of Gd-DTPA and SI
correlated linearly between up to 4 mmol/L under inversion
recovery. Beyond 4 mmol/L, SI decreased with increased 
Gd-DTPA concentration. The plot of SI versus concentration of
Gd-DTPA solutions is shown in Fig. 1a.
In the series of test tubes filled with different concentrations
of Gd-DTPA, SI and concentration of Gd-DTPA correlated
linearly up to 4 mmol/L under inversion recovery. Beyond 
4 mmol/L, SI decreased with increased Gd-DTPA concentra-
tion. In this case, the plot of SI versus concentration of Gd-DTPA
solutions is shown in Fig. 1b.According to these results, for both
individual and collection tube samples together, Gd-DTPA
concentrations up to 4 mmol/L should correlate linearly with SI
of MRI using IR pulse sequence. As Fig. 1 shows, the shape of
the calibration curves generated by each sample is similar to
that for a series of samples in a simple phantom. R1 and R2
relaxivities for aqueous Gd-DTPA solutions were found to be
3.7/mmol per L/s and 4.8/mmol per L/s, respectively.
Signal intensity and concentration of Gd-DTPA
solutions in the presence of sodium chloride
The effect of a biological fluid, such as sodium chloride, on the
signal intensity for a water phantom containing different
concentrations of Gd-DTPA and 5 mol/L NaCl was investigated.
In vitro SI were measured by using transverse images of 
the samples. Figure 2 demonstrates the correlation between 
SI and aqueous solutions of sodium chloride with different
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concentrations of Gd-DTPA. As can be seen from Fig. 2, SI
correlated linearly with Gd-DTPA concentration in the range of
less than 4 mmol/L. The overall intensity shape of this curve
was approximately similar to that observed for Gd-DTPA.
Signal intensity and concentration of Gd-DTPA
with different sodium chloride solutions
The variation in SI from a water phantom consisting of Gd-DTPA
(4 mmol/L) with varying concentrations of sodium chloride is
shown in Fig. 3. The resulting signal intensities are affected
slightly by the concentration of sodium chloride. Regressions 
of signal intensities against Gd concentrations for in vitro
measurements were always of good quality (Figs 2,3) with very
low values of the mean square deviation. As can be seen from
Fig. 3, SI slightly decreases with increased sodium chloride
concentration; however, no significant changes were observed
in the SI near isotonic solution (0.15 mmol/L of NaCl) when
compared to water.
Signal intensity of blood samples with different
Gd-DTPA concentrations
The signal enhancement properties of Gd-DTPA in blood
samples were observed to rapidly increase non-linearly at a
concentration of 1 mmol/L Gd-DTPA (Fig. 4). Above this con-
centration, SI decreased with increased Gd-DTPA concentra-
tion. In the concentration range studied, for low concentrations
of Gd-DTPA (0–1 mmol/L in blood), a positive enhancement
induced by the contrast agent was observed. T1 relaxation time
measurements were performed to confirm the validity of the
results. T1 values for blood containing 1 mmol/L of Gd-DTPA
and blood without Gd-DTPA using an IR sequence were 200 ms
and 1040 ms, respectively. R1 and R2 relaxivities for Gd-DTPA in
blood were found to be 7.5/mmol per L/s and 10.7/mmol per L/s,
respectively, and are reported for the first time.
The SI measurements of melanoma cells with different
concentrations of Gd-DTPA (0–6 mmol/L) were measured.
A reference water phantom was included in the imaging plane
to correct for system variation, which is up to 25% less than that
for an aqueous solution of Gd-DTPA for a given concentration.
As Fig. 5 demonstrates, the enhancement ratio does not
increase linearly with gadolinium concentration in melanoma.
In addition, T1 relaxation time measurements for aqueous
solutions of Gd-DTPA (0.5 mmol/L) and melanoma cells with
Gd-DTPA (0.5 mmol/L) were 1800 ms and 1100 ms, respect-
ively. Table 1 shows T1 relaxation time measurements of
melanoma cells using other magnetic field strengths for
comparison. As can be seen from this table, T1 values for
melanoma cells increase with increasing magnetic field
strength. R1 and R2 relaxivities in melanoma cells were found to
be 15.6/mmol per L/s and 27/mmol per L/s, respectively.
Fig. 1. Plot of normalized MRI signal intensity (SI). (a) Individual tubes
and (b) collection tubes as a function of gadolinium–diethylene triamine
penta-acetic acid (Gd-DTPA) concentration. (Peak response of signal
intensity at 4 mmol/L Gd-DTPA concentration). The signal intensifica-
tion at low concentrations of Gd-DTPA is due to T1 shortening; the loss
of signal at higher Gd-DTPA concentrations is due to T2 shortening.
Fig. 2. Plot of normalized MRI signal intensity (SI) as a function 
of gadolinium–diethylene triamine pentaacetic acid (Gd-DTPA) con-
centration in 5 mol/L sodium chloride solution.
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DISCUSSION
Signal intensity is the relative brightness level in an MRI. There
are many different parameters that affect SI and the contrast
obtained from various tissues in MR images.6 Intrinsic
parameters that are primarily responsible for the contrast
obtainable in MR images are the proton densities and spin
relaxation times. Extrinsic imaging factors that are under
operator control are pulse sequence time, pulse timing
parameters, paramagnetic contrast agent and radiofrequency
pulse.
Gd-DTPA is one of only a few contrast agents available
clinically for MRI at present.1 Application of Gd-DTPA has made
dynamic MRI of several organs and tissues possible, especially
in cancer tissue at low magnetic field strengths.9–11 However, the
contrast enhancement effect of Gd-DTPA varies according to
the pulse sequences,12 magnetic field strength13 and Gd-DTPA
concentration.3
Paramagnetic contrast agents, such as Gd-DTPA, may
cause field-dependent changes in the nuclear spin relaxation
rates and the effects on the gadolinium concentration are linear.
Of course, the effect of data acquisition parameters, TE and TR in
a spin-echo pulse sequence on the SI is given by the following
equation:
(SI) = A . exp(– TE/T2) [1 – exp(– TR/T1)]
where A is a constant. Both TR and TE are a linear function of
gadolinium concentration. The correlation curve of SI and
gadolinium concentration will be a function of TE and TR; that is, 
a shorter TR will move the turn-over seen to higher gadolinium
concentrations as will a shorter TE.
In CT or scintigraphy, the concentration of contrast medium
or radioisotope almost correlates linearly with the CT number 
or radioactivity, whereas the concentration of Gd-DTPA does
not correlate with SI in MRI,13 the reason being that Gd-DTPA
has both T1 and T2 shortening effects. At low Gd-DTPA
concentrations, the T1 shortening effect is dominant, and at high
concentrations, the T2 shortening effect is dominant.3,6 In the
latter condition, SI decreases with increasing Gd-DTPA
concentration, as shown in this work. Signal plateaus at a high
Fig. 3. Plot of normalized MRI signal intensity (SI) as a function
concentration of sodium chloride solutions with constant gadolinium–
diethylene triamine penta-acetic acid (Gd-DTPA) (4 mmol/L).
Fig. 4. Plot of normalized MRI signal intensity as a function of
gadolinium–diethylene triamine penta-acetic acid (Gd-DTPA) in blood.
Fig. 5. Plot of normalized MRI signal intensity as a function of
gadolinium–diethylene triamine penta-acetic acid (Gd-DTPA) con-
centration in melanoma cells.
Table 1. Longitudinal (T1) relaxation measurements reported for 
ex vivo human melanoma cells with different magnetic field strengths8,25
Magnetic field strength (T) T1 relaxation (s)
1.4 1.0
1.9 1.2
2.7 1.3
7.0* 1.5*
*Measurement of T1 in the present work.
Gd-DTPA concentration are caused by a complete relaxation
between pulses, resulting in the sequence becoming proton
density or PD-weighted instead of T1-weighted. However, the
ideal contrast agent for positive-enhanced MRI should shorten
the T1 value but not change the T2 value. Therefore, para-
magnetic agents, such as Gd-DTPA, are known as T1 agents
resulting in MR T1-weighted images.14 For this reason, one of
the important issues is the acceptable concentration of para-
magnetic ion or contrast agents, especially the concentration of
Gd-DTPA, under T1-weighted images.
There have been several reports on tissue concentration of
Gd-DTPA in animals at low magnetic field strength.3,15 Using a
0.35 Tesla resist NMR unit, Brasch et al. showed that SI was
enhanced with aqueous solutions of Gd-DTPA concentrations
in the range of 0–5 mmol/L but then decreases with increasing
Gd-DTPA concentrations under spin-echo sequences.16 Takeda
and his colleagues demonstrated the use of MRI to determine
the in vivo SI versus different concentrations of Gd-DTPA at a
low magnetic field strength (1.5 Tesla) in an aqueous solution of
Gd-DTPA.3 They showed that SI correlated linearly with the
concentration of Gd-DTPA between 0 mmol/L and 3.0 mmol/L
under spin-echo or gradient-echo sequences in rat kidney.
The optimal pulse sequence will vary with field strength
because of the frequency dependence of T1-relaxation times,4,15
but the correlation between SI and Gd-DTPA concentration at
high magnetic field strengths has not yet been investigated.
Consequently, this report is the first to investigate in vitro
relationships for machine parameters and pulse sequences at a
high magnetic field strength of 7.0 Tesla.
The results of this work show that SI correlates linearly 
with Gd-DTPA concentrations from up to 4 mmol/L at a high
magnetic field strength under IR pulse sequence (T1-weighted)
in aqueous solutions of Gd-DTPA.The results also indicate that
a significantly improved fit to Gd-DTPA solutions in 4 mmol/L
and sodium chloride at 4 mmol/L could be achieved by using 
T1-weighted MRI (Fig. 3).The loss of SI at higher concentrations
of Gd-DTPA is due to T2-shortening but the signal intensification
at low concentrations of Gd-DTPA is due to T1-shortening.
These imaging data provide more detailed information about
aqueous solutions of Gd-DTPA than had been reported
previously by Takeda et al. and Brasch et al.3,16
R1 and R2 relaxivities for aqueous Gd-DTPA solutions is con-
sistent with the literature and supports the theory that relaxivity
is dependent on magnetic field strength.1,6
The relaxation times are indirect measures of the inter-
actions that occur between water molecules and other cell
constituents.17 Water molecules in biological tissue can be
classified into two types: free and bound.6 Free water is by far
the more abundant and behaves like ordinary water in terms of
its NMR properties. The bound fraction consists of water
molecules that are bound rather firmly to the surface of
molecules (cell membranes, protein, etc.) and are therefore far
less mobile than their free counterparts. The limited mobility of
bound water molecules causes a shorter T1 (1–10 ms) relaxa-
tion time compared to water in the free state (2000 ms). In 
the present work the T1 relaxation time was 2500 ms in free
water.
As described earlier, blood has a shorter T1 relaxation time
and, hence, higher relaxivity values than that of water. For this
reason, the SI in blood increases non-linearly with Gd-DTPA
concentration to reach a maximum (1 mmol/L), and then
decreases non-linearly as the concentration continues to
increase. A similar decrease in SI has been observed with other
paramagnetic agents; for example, ferric ions and nitroxide free
radicals in high concentrations.18,19 Signal enhancements in the
present study were slightly larger than those reported by Siauve
et al.,20 in which the signal enhancements of carboxymethyl-
dextran-Gd-DTPA in blood increased up to a concentration 
of 0.5 mmol/L at 4.7 Tesla. The correlation between SI and 
Gd-DTPA concentration in biological samples agrees with
similar results obtained by Weinmann et al.2
T1 relaxation values of tissues have been reported to vary
with frequency and hence the applied magnetic field strength.6
On the other hand, it must be noted that the optimal pulse
sequence will vary with field strength because of the frequency
dependence of tissue T1 relaxation times. A number of models
that describe the influence of magnetic field strength on both 
T1 and T2 relaxation times predict a significant increase in T1 and
a decrease in T2 when using higher magnetic field strengths.1,6
This result is consistent with the theory mentioned in the
present article, which shows a higher T1 relaxation time for
melanoma cells at 7.0 Tesla compared to a lower magnetic field
strength reported previously.8,25
Magnetic resonance imaging has significant potential for the
detection and evaluation of melanoma.8,21 The SI of malignant
melanoma cells have been noted to differ from most other
human neoplasms on MR images because melanomas often
have shorter proton relaxation times.22 Intratumoral melanin
itself23,24 and naturally occurring paramagnetic cations bound 
to melanin25 have each been postulated as the major cause of
shortened relaxation times in malignant melanomas. Atlas et al.
have shown a correlation between shortening of T1 and
increasing melanin content.8 Of course, a dipolar interaction
can be associated with the presence of many other para-
magnetic substances, including naturally occurring metals such
as Fe3+, Cu2+ or Mn2+.26 In particular, Fe3+ has been shown to
bind to melanin excess paramagnetic and contribute signifi-
cantly to the shortening of T1 relaxation times.25 For this reason,
maximum SI versus Gd-DTPA in melanoma cells is lower than
that for an aqueous solution. The aggregation of melanin into
other macromolecular particles is another reason for the non-
linear relationship between SI and Gd-DTPA in melanoma cells.
R1 and R2 relaxivities in melanoma cells were greater than
that for aqueous Gd-DTPA solutions. Several mechanisms can
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be suggested to explain the differences between the measured
relaxivities of melanoma cells and aqueous solution in the
presence of Gd-DTPA in in vitro conditions. These include a
variation in the mechanism of rapid exchange of water
molecules in aqueous Gd-DTPA solution and melanoma,
macromolecular binding of contrast agent, and diffusion of
protons through susceptibility gradients.
The results of the present study have confirmed that the
binding of paramagnetic metal ions to the macromolecules of
tissues has the largest effect on relaxation rates. These results
are in reasonable agreement with the literature and indicate 
that the Gd-DTPA molecules pass through fenestrations in the
membrane of abnormal cells or melanoma cells.25
Calibration curves are necessary for the adjustment of SI
measurements and to provide an image of the highest quality. In
the present report the measurements of SI versus Gd-DTPA
concentration provides an insight into the MR enhancement
ability of gadolinium. Although at this stage identification of 
the SI under in vivo conditions is not clear, it is possible that
increases in SI are related to the T1 shortening effect, as
measurements show the T1 relaxation times are 200 ms and
1040 ms for blood samples with and without 1 mmol/L of 
Gd-DTPA.
Differences between these data and previous experiments
arise from different pulse sequences, magnetic field strengths
and the method of measuring SI. But from the point of view of
the correlation between SI and Gd-DTPA concentration, all
results are similar.
Generally, the contrast agent is effective in enhancing T1 and
T2 relaxation rates. Water and blood were used to estimate the
error caused from using incorrect calibration curves. The
calibration curves generated by direct signal measurements of
water with different Gd-DTPA concentrations (0–6 mmol/L) by
using inversion recovery pulse sequence are y = 26.2x + 17.6
and y = 26.9x + 15.6. On the other hand, the calibration curves
for blood and melanoma cells with different Gd-DTPA con-
centrations obtained using inversion recovery pulse sequence
show that a linear correlation does not exist between signal
intensity and Gd-DTPA concentration.
CONCLUSIONS
In aqueous solutions of paramagnetic ions, a linear relationship
between the paramagnetic ion concentration and relaxation
rates is expected.6 This relationship has been verified experi-
mentally for aqueous Gd-DTPA solutions, Gd-DTPA solution in
blood and in melanoma cells.These empirical data suggest that
even in blood and soft tissues, T1 and T2 relaxation rates are
proportional to the tissue gadolinium concentration.3,13
In addition, a number of models describing the influence 
of the magnetic field strength on both T1 and T2 relaxation times
predicted a significant increase in T1 and a decrease in T2 when
using higher magnetic field strengths.4,6 This decrease was
possibly due to the concentration of susceptibility effects at
elevated magnetic fields and diffusion of spins, resulting in a
decreased value for T2.5 Diffusion of spins through magnetic
field variations introduces non-static inhomogeneities and
leads to MR signal loss, even for pulse sequences that correct
completely for static inhomogeneities. Magnetic susceptibility of
samples for high concentrations of Gd-DTPA is responsible 
for T2 shortening because of its comparatively large dipolar
relaxation contribution, resulting in MR signal loss.
The present study has conclusively demonstrated that SI in
aqueous solutions of Gd-DTPA are different to those for blood
and melanoma.These results are similar to observations made
by Tofts et al.27 of phantom samples and tissue-equivalent
materials with regard to relaxometry.
The results of the present study show several important
findings. First, SI correlates with Gd-DTPA concentrations from
0 to 4 mmol/L in aqueous solutions of Gd-DTPA with high
magnetic field apparatus. Second, SI is non-linear with Gd-
DTPA concentration in blood within the range 0–6 mmol/L.
Third, signal enhancement does not increase linearly with
gadolinium concentration in melanoma cells in the range
studied. Fourth, dynamic MRI (T1-weighted) is possible under
ordinary inversion recovery pulse sequence using a high
magnetic field strength. It follows that images of high quality
might be obtained if gadolinium concentrations within the
compartments could be estimated.
The results of this work may help in the design of chemo-
therapeutic agents. The Gd-DTPA permeability study can
provide information about tissue uptake of small chemo-
therapeutic agents for high resolution MR imaging studies.
The paramagnetic contribution to the relaxation rates makes
quantitative studies of the uptake of paramagnetic contrast
agents possible. These findings may also be useful for MRI of
melanoma cells at 7.0 Tesla.
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